Amgen (AMGN) Upgraded by Goldman Sachs (GS)

Amgen (NASDAQ: AMGN) was upgraded by Goldman Sachs (NYSE:GS) on Friday.

They boosted the company from a "Sell" rating to a "Neutral" rating.

Earlier in the week UBS (NYSE: UBS) also boosted its price target on the company to $59.00. They have a "Neutral" rating on the company.

Amgen was trading at $60.78, up $2.16, or 3.68 percent, as of 12:03 PM EST.